Huadong Medicine: Announcement on the adjustment of the repurchase price of restricted stocks incentive plan for the year 2022 (updated)
Huadong Medicine: Legal Opinion of Zhejiang TianCe Law Firm on the Adjustment of Restricted Stock Grant Price and Redemption and Cancellation of Restricted Stocks of Huadong Medicine Co., Ltd.'s Restricted Stock Incentive Plan for 2022.
Huadong Medicine: Correction announcement regarding the repurchase and cancellation of restricted stocks.
Huadong Medicine: Announcement Regarding Repurchasing and Cancelling Certain Restricted Stocks (Updated)
Huadong Medicine: The supervisory board's verification opinion on the adjustment of the 2022 restricted stock incentive plan repurchase price and repurchase cancellation of some restricted stocks (updated).
Huadong Medicine: Announcement on the Adjustment of Restricted Stock Incentive Plan Repurchase Price for 2022 (Before Update)
Huadong Medicine: Legal Opinion of Zhejiang Tianze Law Firm on Huadong Pharmaceutical Co., Ltd.'s 2022 Restricted Stock Incentive Plan to Adjust Restricted Stock Repurchase Prices and Repurchase and Cancellation of Some Restricted Shares
Huadong Medicine: The Supervisory Board's verification opinion on the adjustment of the repurchase price and cancellation of restricted stocks of the 2022 restricted stock incentive plan (pre-update).
Huadong Medicine: Announcement on the Proposed Repurchase and Cancellation of Restricted Stocks (pre-update)
Huadong Medicine: 2023 Annual Equity Distribution Implementation Notice
Huadong Pharmaceutical: 2023 Profit Distribution Plan Announcement
Huadong Pharmaceutical: Announcement on the completion of the cancellation of some restricted stock repurchases
Huadong Pharmaceutical: Announcement on the pledge and cancellation of the pledge of some of the shares of the controlling shareholder
Huadong Pharmaceutical: Announcement on the pledge and cancellation of the pledge of some of the shares of the controlling shareholder
Huadong Pharmaceutical: Announcement on the controlling shareholder\'s partial share pledge
Huadong Pharmaceutical: Reminder Notice on the 2022 Restricted Stock Incentive Plan for the First Grant of Restricted Stocks to Restricted Stocks, First Release Period, and Release of Restricted Shares from Listing and Circulation
Huadong Pharmaceutical: Announcement on the 2022 Restricted Stock Incentive Plan for the First Time Granting Restricted Stocks to Restricted Stocks, First Release Period, and Achievements in Lifting Sales Restriction Conditions
Huadong Pharmaceutical: Guosheng Securities Co., Ltd.\'s independent financial adviser report on Huadong Pharmaceutical Co., Ltd.\'s 2022 restricted stock incentive plan for the first time granting restricted shares, the first lifting period, and the achie
Huadong Pharmaceutical: The Supervisory Committee\'s verification opinions on the company\'s 2022 restricted stock incentive plan for the first time granting restricted stocks, the first lifting period, lifting the conditions for lifting the restrictions,
Huadong Pharmaceutical: Announcement on Adjusting the Repurchase Price of the 2022 Restricted Stock Incentive Plan
No Data